{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:07:57Z","timestamp":1788318477213,"version":"build-2803163510"},"reference-count":52,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0211","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T13:25:57Z","timestamp":1734355557000},"source":"Crossref","is-referenced-by-count":8,"title":["The epidemiology and diagnosis of measles\u2014special aspects relating to low incidence"],"prefix":"10.3238","author":[{"given":"Dorothea","family":"Matysiak-Klose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Mankertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"10.3238\/arztebl.m2024.0211_ref1","doi-asserted-by":"crossref","unstructured":"Bloch AB, Orenstein WA, Ewing WM, et al.: Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 1985; 75: 676–83.","DOI":"10.1542\/peds.75.4.676"},{"key":"10.3238\/arztebl.m2024.0211_ref2","doi-asserted-by":"crossref","unstructured":"Remington PL, Hall WN, Davis IH, Herald AL, Gunn RA: Airborne transmission of measles in a physician‘s office. JAMA 1985; 253: 1574–7.","DOI":"10.1001\/jama.1985.03350350068022"},{"key":"10.3238\/arztebl.m2024.0211_ref3","doi-asserted-by":"crossref","unstructured":"de Jong Jd: The survival of measles virus in air. Antonie Van Leeuwenhoek 2005; 29: 327–8.","DOI":"10.1007\/BF02046084"},{"key":"10.3238\/arztebl.m2024.0211_ref4","unstructured":"Holzmann H: Masern. Osterr Arzteztg 2015; 1\/2: 20–30."},{"key":"10.3238\/arztebl.m2024.0211_ref5","doi-asserted-by":"crossref","unstructured":"Perry RT, Halsey NA: The clinical significance of measles: a review. J Infect Dis 2004; 189 (Suppl 1): S4–16.","DOI":"10.1086\/377712"},{"key":"10.3238\/arztebl.m2024.0211_ref6","doi-asserted-by":"crossref","unstructured":"Sch\u00f6nberger K, Ludwig MS, Wildner M, Weissbrich B: Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One 2013; 8: e68909.","DOI":"10.1371\/journal.pone.0068909"},{"key":"10.3238\/arztebl.m2024.0211_ref7","doi-asserted-by":"crossref","unstructured":"Wendorf KA, Winter K, Zipprich J, et al.: Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated. Clin Infect Dis 2017; 65: 226–32.","DOI":"10.1093\/cid\/cix302"},{"key":"10.3238\/arztebl.m2024.0211_ref8","doi-asserted-by":"crossref","unstructured":"Garg RK, Mahadevan A, Malhotra HS, Rizvi I, Kumar N, Uniyal R: Subacute sclerosing panencephalitis. Rev Med Virol 2019; 29: e2058.","DOI":"10.1002\/rmv.2058"},{"key":"10.3238\/arztebl.m2024.0211_ref9","doi-asserted-by":"crossref","unstructured":"Petrova VN, Sawatsky B, Han AX, et al.: Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles. Sci Immunol 2019; 4: eaay6125.","DOI":"10.1126\/sciimmunol.aay6125"},{"key":"10.3238\/arztebl.m2024.0211_ref10","doi-asserted-by":"crossref","unstructured":"Mina MJ, Kula T, Leng Y, et al.: Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 2019; 366: 599–606.","DOI":"10.1126\/science.aay6485"},{"key":"10.3238\/arztebl.m2024.0211_ref11","doi-asserted-by":"crossref","unstructured":"Gadroen K, Dodd CN, Masclee GMC, et al.: Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ open 2018; 8: e021465.","DOI":"10.1136\/bmjopen-2017-021465"},{"key":"10.3238\/arztebl.m2024.0211_ref12","doi-asserted-by":"crossref","unstructured":"Kimura H, Shirabe K, Takeda M, et al.: The association between documentation of koplik spots and laboratory diagnosis of measles and other rash diseases in a National Measles Surveillance Program in Japan. Front Microbiol 2019; 10: 269.","DOI":"10.3389\/fmicb.2019.00269"},{"key":"10.3238\/arztebl.m2024.0211_ref13","doi-asserted-by":"crossref","unstructured":"Di Pietrantonj C, Rivetti A, Marchione P, Debalini M, Demicheli V: Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev 2020; 4: CD004407.","DOI":"10.1002\/14651858.CD004407.pub4"},{"key":"10.3238\/arztebl.m2024.0211_ref14","doi-asserted-by":"crossref","unstructured":"Wichmann O, Hellenbrand W, Sagebiel D, et al.: Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J 2007; 26: 782–6.","DOI":"10.1097\/INF.0b013e318060aca1"},{"key":"10.3238\/arztebl.m2024.0211_ref15","doi-asserted-by":"crossref","unstructured":"Anderson RM, May RM: Directly transmitted infections diseases: control by vaccination. Science 1982; 215: 1053–60.","DOI":"10.1126\/science.7063839"},{"key":"10.3238\/arztebl.m2024.0211_ref16","doi-asserted-by":"crossref","unstructured":"Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O: Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother 2014; 10: 476–84.","DOI":"10.4161\/hv.26986"},{"key":"10.3238\/arztebl.m2024.0211_ref17","unstructured":"Robert Koch-Institut: Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2019. www.rki.de\/DE\/Content\/Infekt\/Jahrbuch\/Jahrbuch_2019.pdf?__blob=publicationFile (last accessed on 31 October 2024)."},{"key":"10.3238\/arztebl.m2024.0211_ref18","unstructured":"Walter AO, Paul AO, Kathryn ME, Stanley AP: Plotkin‘s vaccines. Philadelphia, PA: Elsevier 2024."},{"key":"10.3238\/arztebl.m2024.0211_ref19","doi-asserted-by":"crossref","unstructured":"Takla A, Wichmann O, Rieck T, Matysiak-Klose D: Measles incidence and reporting trends in Germany, 2007–2011. Bull World Health Organ 2014; 92: 742–9.","DOI":"10.2471\/BLT.13.135145"},{"key":"10.3238\/arztebl.m2024.0211_ref20","unstructured":"World Health Organizsation: EpiData measles and rubella. World Health Organization 2024. www.who.int\/andorra\/publications\/m\/item\/epidata-8–2024 (last accessed on 31 October 2024)."},{"key":"10.3238\/arztebl.m2024.0211_ref21","doi-asserted-by":"crossref","unstructured":"Markowitz LE, Preblud SR, Fine PE, Orenstein WA: Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990; 9: 101–10.","DOI":"10.1097\/00006454-199002000-00008"},{"key":"10.3238\/arztebl.m2024.0211_ref22","unstructured":"Rieck T, Feig M, Siedler A: Impfquoten von Kinderschutzimpfungen in Deutschland – aktuelle Ergebnisse aus der RKI-Impfsurveillance. Epid Bull 2022; 48: 3–25."},{"key":"10.3238\/arztebl.m2024.0211_ref23","unstructured":"Seefeld L, Horstk\u00f6tter N, M\u00fcller U, et al.: Einstellungen, Wissen und Verhalten von Erwachsenen und Eltern gegen\u00fcber Impfungen – Ergebnisse der Repr\u00e4sentativbefragung 2021 zum Infektionsschutz. BZgA-Forschungsbericht. K\u00f6ln: Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung, 2022."},{"key":"10.3238\/arztebl.m2024.0211_ref24","unstructured":"World Health Organization: Eliminating measles and rubella in the WHO European region; Integrated guidance for surveillance, outbreak response and verification of elimination. Copenhagen: WHO Regional Office for Europe 2024."},{"key":"10.3238\/arztebl.m2024.0211_ref25","doi-asserted-by":"crossref","unstructured":"Funk S, Knapp JK, Lebo E, et al.: Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination. BMC medicine 2019; 17: 180.","DOI":"10.1186\/s12916-019-1413-7"},{"key":"10.3238\/arztebl.m2024.0211_ref26","doi-asserted-by":"crossref","unstructured":"Hayman DTS: Measles vaccination in an increasingly immunized and developed world. Hum Vaccin Immunother 2019; 15: 28–33.","DOI":"10.1080\/21645515.2018.1517074"},{"key":"10.3238\/arztebl.m2024.0211_ref27","doi-asserted-by":"crossref","unstructured":"Gay NJ, Hesketh LM, Morgan-Capner P, Miller E: Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995; 115: 139–56.","DOI":"10.1017\/S0950268800058209"},{"key":"10.3238\/arztebl.m2024.0211_ref28","doi-asserted-by":"crossref","unstructured":"Wallinga J, Heijne JC, Kretzschmar M: A measles epidemic threshold in a highly vaccinated population. PLoS medicine 2005; 2: e316.","DOI":"10.1371\/journal.pmed.0020316"},{"key":"10.3238\/arztebl.m2024.0211_ref29","doi-asserted-by":"crossref","unstructured":"Gay NJ: The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis 2004; 189 (Suppl 1): S27–S35.","DOI":"10.1086\/381592"},{"key":"10.3238\/arztebl.m2024.0211_ref30","doi-asserted-by":"crossref","unstructured":"van Boven M, Kretzschmar M, Wallinga J, O‘Neill PD, Wichmann O, Hahn\u00e9 S: Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface 2010; 7: 1537–44.","DOI":"10.1098\/rsif.2010.0086"},{"key":"10.3238\/arztebl.m2024.0211_ref31","unstructured":"World Health Organization: Eliminating measles and rubella. Framework for the verification process in the WHO European region 2014. World Health Organization, Regional Office for Europe 2014."},{"key":"10.3238\/arztebl.m2024.0211_ref32","doi-asserted-by":"crossref","unstructured":"World Health Organization: Measles vaccines: WHO position paper, April 2017—recommendations. Vaccine 2019; 37: 219–22.","DOI":"10.1016\/j.vaccine.2017.07.066"},{"key":"10.3238\/arztebl.m2024.0211_ref33","doi-asserted-by":"crossref","unstructured":"Dixon MG, Ferrari M, Antoni S, et al.: Progress toward regional measles elimination—worldwide, 2000–2020. MMWR Morb Mortal Wkly Rep 2021; 70: 1563–9.","DOI":"10.15585\/mmwr.mm7045a1"},{"key":"10.3238\/arztebl.m2024.0211_ref34","doi-asserted-by":"crossref","unstructured":"Minta AA, Ferrari M, Antoni S, et al.: Progress toward measles elimination—worldwide, 2000–2022. MMWR Morb Mortal Wkly Rep 2023; 72: 1262–8.","DOI":"10.15585\/mmwr.mm7246a3"},{"key":"10.3238\/arztebl.m2024.0211_ref35","unstructured":"World Health Organization: Global measles and rubella monthly. Update. World Health 2024. https:\/\/immunizationdata.who.int\/global?topic=Provisional-measles-and-rubella-data&location= (last accessed on 31 October 2024)."},{"key":"10.3238\/arztebl.m2024.0211_ref36","doi-asserted-by":"crossref","unstructured":"Maltezou HC, Medic S, Cassimos DC, Effraimidou E, Poland GA: Decreasing routine vaccination rates in children in the COVID-19 era. Vaccine 2022; 40: 2525–7.","DOI":"10.1016\/j.vaccine.2022.03.033"},{"key":"10.3238\/arztebl.m2024.0211_ref37","unstructured":"Nationale Verifizierungskommission Masern\/R\u00f6teln: Berichte der Nationalen Verifizierungskommission Masern\/R\u00f6teln beim Robert Koch-Institut. www.rki.de\/DE\/Content\/Kommissionen\/NAVKO\/Berichte\/Berichte_node.html (last accessed on 31 October 2024)."},{"key":"10.3238\/arztebl.m2024.0211_ref38","doi-asserted-by":"crossref","unstructured":"Filardo TD, Crooke SN, Bankamp B, et al.: Measles and rubella diagnostic and classification challenges in near- and post-elimination countries. Vaccines 2024; 12: 697.","DOI":"10.3390\/vaccines12060697"},{"key":"10.3238\/arztebl.m2024.0211_ref39","doi-asserted-by":"crossref","unstructured":"H\u00fcbschen JM, Bork SM, Brown KE, et al.: Challenges of measles and rubella laboratory diagnostic in the era of elimination. Clin Microbiol Infect 2017; 23: 511–5.","DOI":"10.1016\/j.cmi.2017.04.009"},{"key":"10.3238\/arztebl.m2024.0211_ref40","unstructured":"Williams D, Penedos A, Bankamp B, et al.: Update: circulation of active genotypes of measles virus and recommendations for use of sequence analysis to monitor viral transmission. Wkly Epidemiol Rec 2022; 39: 485–92."},{"key":"10.3238\/arztebl.m2024.0211_ref41","doi-asserted-by":"crossref","unstructured":"Helfand RF, Kebede S, Gary HE Jr, Beyene H, Bellini WJ: Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol 1999; 6: 178–80.","DOI":"10.1128\/CDLI.6.2.178-180.1999"},{"key":"10.3238\/arztebl.m2024.0211_ref42","doi-asserted-by":"crossref","unstructured":"Semmler G, Aberle SW, Griebler H, et al.: Performance of four IgM antibody assays in the diagnosis of measles virus primary infection and cases with a serological profile indicating reinfection. J Clin Microbiol 2021; 59: e02047–20.","DOI":"10.1128\/JCM.02047-20"},{"key":"10.3238\/arztebl.m2024.0211_ref43","doi-asserted-by":"crossref","unstructured":"Woods CR: False-positive results for immunoglobulin M serologic results: explanations and examples. J Pediatric Infect Dis Soc 2013; 2: 87–90.","DOI":"10.1093\/jpids\/pis133"},{"key":"10.3238\/arztebl.m2024.0211_ref44","doi-asserted-by":"crossref","unstructured":"Bolotin S, Lim G, Dang V, et al.: The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009–2014. PLoS One 2017; 12: e0181172.","DOI":"10.1371\/journal.pone.0181172"},{"key":"10.3238\/arztebl.m2024.0211_ref45","doi-asserted-by":"crossref","unstructured":"Patel MK, Goodson JL, Alexander JP, et al.: Progress toward regional measles elimination—worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep 2020; 69: 1700–5.","DOI":"10.15585\/mmwr.mm6945a6"},{"key":"10.3238\/arztebl.m2024.0211_ref46","doi-asserted-by":"crossref","unstructured":"Hahn\u00e9 SJM, Nic Lochlainn LM, van Burgel ND, et al.: Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis 2016; 214: 1980–6.","DOI":"10.1093\/infdis\/jiw480"},{"key":"10.3238\/arztebl.m2024.0211_ref47","doi-asserted-by":"crossref","unstructured":"Bonneton M, Antona D, Danis K, Ait-Belghiti F, Levy-Bruhl D: Are vaccinated measles cases protected against severe disease? Vaccine 2020; 38: 4516–9.","DOI":"10.1016\/j.vaccine.2020.05.005"},{"key":"10.3238\/arztebl.m2024.0211_ref48","doi-asserted-by":"crossref","unstructured":"Gibney KB, Attwood LO, Nicholson S, et al.: Emergence of attenuated measles illness among IgG-positive\/IgM-negative measles cases: Victoria, Australia, 2008–2017. Clin Infect Dis 2020; 70: 1060–7.","DOI":"10.1093\/cid\/ciz363"},{"key":"10.3238\/arztebl.m2024.0211_ref49","doi-asserted-by":"crossref","unstructured":"Hubiche T, Brazier C, Vabret A, Reynaud S, Roudiere L, Del Giudice P: Measles transmission in a fully vaccinated closed cohort: data from a nosocomial clustered cases in a teenage psychiatric unit. Pediatr Infect Dis J 2019; 38: e230–2.","DOI":"10.1097\/INF.0000000000002372"},{"key":"10.3238\/arztebl.m2024.0211_ref50","doi-asserted-by":"crossref","unstructured":"Iwamoto M, Hickman CJ, Colley H, et al.: Measles infection in persons with secondary vaccine failure, New York City, 2018–19. Vaccine 2021; 39: 5346–50.","DOI":"10.1016\/j.vaccine.2021.07.078"},{"key":"10.3238\/arztebl.m2024.0211_ref51","doi-asserted-by":"crossref","unstructured":"Schenk J, Abrams S, Theeten H, Van Damme P, Beutels P, Hens N: Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2021; 21: 286–95.","DOI":"10.1016\/S1473-3099(20)30442-4"},{"key":"10.3238\/arztebl.m2024.0211_ref52","unstructured":"Robert Koch-Institut: RKI-Ratgeber Masern. Epid Bull 2024; 46: 3–23. DOI 10.25646\/12902."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T13:26:47Z","timestamp":1734355607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":52,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0211","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}